What Can Phages Tell Us About Host-Pathogen Coevolution?
Overview
Authors
Affiliations
The outcomes of host-parasite interactions depend on the coevolutionary forces acting upon them, but because every host-parasite relation is enmeshed in a web of biotic and abiotic interactions across a heterogeneous landscape, host-parasite coevolution has proven difficult to study. Simple laboratory phage-bacteria microcosms can ameliorate this difficulty by allowing controlled, well-replicated experiments with a limited number of interactors. Genetic, population, and life history data obtained from these studies permit a closer examination of the fundamental correlates of host-parasite coevolution. In this paper, I describe the results of phage-bacteria coevolutionary studies and their implications for the study of host-parasite coevolution. Recent experimental studies have confirmed phage-host coevolutionary dynamics in the laboratory and have shown that coevolution can increase parasite virulence, specialization, adaptation, and diversity. Genetically, coevolution frequently proceeds in a manner best described by the Gene for Gene model, typified by arms race dynamics, but certain contexts can result in Red Queen dynamics according to the Matching Alleles model. Although some features appear to apply only to phage-bacteria systems, other results are broadly generalizable and apply to all instances of antagonistic coevolution. With laboratory host-parasite coevolutionary studies, we can better understand the perplexing array of interactions that characterize organismal diversity in the wild.
Chen L, Zhao X, Wongso S, Lin Z, Wang S ISME J. 2024; 18(1).
PMID: 39441988 PMC: 11538992. DOI: 10.1093/ismejo/wrae214.
Phage-driven coevolution reveals trade-off between antibiotic and phage resistance in .
Zhao Y, Shu M, Zhang L, Zhong C, Liao N, Wu G ISME Commun. 2024; 4(1):ycae039.
PMID: 38616926 PMC: 11014889. DOI: 10.1093/ismeco/ycae039.
Characterization of phage evolution and phage resistance in drug-resistant .
Han P, Lin W, Fan H, Tong Y J Virol. 2024; 98(2):e0124923.
PMID: 38189285 PMC: 10878236. DOI: 10.1128/jvi.01249-23.
Current Clinical Landscape and Global Potential of Bacteriophage Therapy.
Hitchcock N, Nunes D, Shiach J, Hodel K, Barbosa J, Alencar Pereira Rodrigues L Viruses. 2023; 15(4).
PMID: 37113000 PMC: 10146840. DOI: 10.3390/v15041020.
Igler C Virus Evol. 2022; 8(2):veac086.
PMID: 36225237 PMC: 9547521. DOI: 10.1093/ve/veac086.